"Conjunctisan B® is specially designed to treat contact lens allergies and counteract their discomfort and degenerative features." Phil Micans PharmB Great Britain
Proven Relief for the following:
Conjunctisan B ® differs from Conjunctisan A ® in that it is indicated specifically for use in the treatment of eye allergies and especially for those who suffer with contact lens problems and agitation.
Conjunctisan B ® corrects the proven damage to the eyes that contact lens cleaning fluids cause over time. Additionally Conjunctisan B ® makes the wearing of contact lenses far more comfortable and bearable.
"I wasn't aware of the established problems associated with long-term contact lens use, now I feel that Conjunctisan B ® provides a kind of insurance for my eyes." C.J., Norway.
With over fifteen years of use in Europe it is completely safe and suitable for prolonged use. Break a vial and instill a couple of drops into each eye several times daily. It should be stored in the fridge when not in use.
Dosage and Application:
Break off the upper part of the vial by twisting it. If no other dose regimen
is recommended by the attending doctor, instill several times daily 1-2 drops
in the conjunctival sac of the eye and possibly also inhale through the nose
by applying slight pressure to the body of the vial.
Intolerance and Risks:
None, when used as prescribed.
Directions:
Special Notes:
For the preservation of the full biological efficacy of Conjunctisan A ®,
these eye-drops are free from preservatives. The presentation in the form of
vials with a unit dose permits the unrestricted action of organotherapeutic
factors. Furthermore, this progressive method of applying eye drops excludes
any risk of infection. Do not store at temperatures of more than 25 degrees
Celsius. Keep the vials in the folding box, where they are protected from light.
Only use clear solutions. Do not use drops after the expiry date marked. Keep
drugs out of the reach of children. Solutions that have turned turbid through
incorrect handling must not be used. For the indication of glaucoma, supervision
by an eye specialist is recommended.
Disclaimer: The above information is the translation of the manufacturer's insert. It is provided under the supplying company's terms and conditions and should not replace the advice of your personal physician.
References:
1. Fuchs J, "Conservative treatment of senile cataract with Conjunctisan
A ®." Klin. Mbl. Augenheilk, 175 (1979), 799-805.
2. Seifert J, Ganser R, Pfleiderer A, Brendel W, "Absorption and distribution
of cytoplasmic organ lysates (Conjunctisan A ® eye-drops), following intraconjunctival
application." Klin. Mbl. Augenheilk, 175 (1979), 795-798.
3. Fuchs J, "The effect of Conjunctisan A ® eye-drops on cataracts."
Med. Monatsschrift, May 1975, Page 224-225.
4. Fuchs J, "Is it possible to influence a senile cataract with drugs?"
Med. Klinik 78, (1983), 171-174.
DISCLAIMER: ALL INFORMATION IS EDUCATIONAL AND PROVIDED UNDER IAS TERMS &
CONDITIONS. IT DOES NOT, AND SHOULD NOT, REPLACE THE ADVICE OF YOUR PHYSICIAN.